The heart's relentless work-100,000 beats daily pumping 2,000 gallons of blood-makes it uniquely vulnerable when cellular machinery fails, oxygen supply falters, or immune attacks turn inward. You'll journey from microscopic injury patterns through ischemic crises, inflammatory assaults, and structural failures to master the diagnostic reasoning and treatment algorithms that distinguish competent clinicians from exceptional ones. This lesson builds your ability to recognize cardiac pathology's signatures, understand why each disease unfolds as it does, and intervene with precision when hearts hang in the balance.
Cardiac pathology transforms abstract disease concepts into tangible cellular realities. Every chest pain, every murmur, every heart failure symptom originates from specific microscopic changes that pathologists decode with mathematical precision. Understanding these cellular signatures unlocks the logic behind every cardiac presentation.
Ischemic Disorders (40% of cardiac deaths)
Cardiomyopathies (25% of heart failure cases)
Valvular Pathology (15% of cardiac interventions)
📌 Remember: CARDIAC pathology classification - Coronary (ischemic), Arrhythmogenic, Restrictive, Dilated, Infiltrative, Acute inflammatory, Congenital. Each category has distinct microscopic signatures with specific timeframes for cellular changes.
| Disease Category | Cellular Hallmark | Timeline | Diagnostic Marker | Prognosis | Key Measurement |
|---|---|---|---|---|---|
| Acute MI | Coagulation necrosis | 6-24 hours | Troponin >50x ULN | 10% mortality | >20% LV involvement |
| Dilated CMP | Myocyte hypertrophy | Months-years | BNP >400 pg/mL | 50% 5-year survival | EF <40% |
| Hypertrophic CMP | Disarray + fibrosis | Years-decades | Septal thickness >15mm | 1% sudden death | Gradient >30 mmHg |
| Restrictive CMP | Interstitial fibrosis | Variable | Elevated filling pressures | Poor if advanced | E/A ratio >2 |
| Myocarditis | Lymphocytic infiltrate | Days-weeks | Endomyocardial biopsy | 80% recovery | >14 cells/mm² |
💡 Master This: Every cardiac pathological process creates specific microscopic fingerprints. Ischemia produces coagulation necrosis, inflammation shows lymphocytic infiltrates, and pressure overload generates concentric hypertrophy. Recognition of these patterns enables precise diagnosis within minutes of microscopic examination.
Understanding cardiac pathology's cellular foundation connects directly to recognizing how these microscopic changes manifest as clinical syndromes and guide therapeutic interventions.
Loading diagram…
Acute Coronary Syndromes (1.5 million cases annually)
Chronic Ischemic Disease (stable angina patterns)
📌 Remember: TIMELINE for MI evolution - Troponin rises (3-6 hours), Inflammation peaks (24-72 hours), Macrophages arrive (3-7 days), Early granulation (1-2 weeks), Late fibrosis (2-8 weeks), Infarct maturation (2-6 months), New equilibrium (>6 months), Endstage remodeling (years).
⭐ Clinical Pearl: Door-to-balloon time <90 minutes reduces mortality by 25% in STEMI patients. Every 30-minute delay increases 1-year mortality by 7.5%. Troponin elevation >50x upper limit indicates large infarct with >20% left ventricular involvement and doubled mortality risk.
| Infarct Location | Coronary Territory | ECG Changes | Complications | Mortality Risk | Wall Motion |
|---|---|---|---|---|---|
| Anterior | LAD | V1-V6 | Pump failure | 15-20% | Hypokinesis |
| Inferior | RCA | II, III, aVF | Heart block | 5-10% | Akinesis |
| Posterior | LCX/RCA | V7-V9 | Mitral regurg | 8-12% | Dyskinesis |
| Lateral | LCX | I, aVL, V5-V6 | Arrhythmias | 6-8% | Aneurysm |
| RV | RCA | V1, V4R | RV failure | Variable | Tricuspid regurg |
Recognizing ischemic patterns establishes the foundation for understanding how inflammatory processes can mimic or complicate coronary disease presentations.
Myocarditis (1-5% of viral infections)
Pericarditis (viral etiology in 80-90% of cases)
Endocarditis (blood culture positive in 85% of cases)
Loading diagram…
📌 Remember: INFLAME criteria for myocarditis - Infiltrate (lymphocytic), Necrosis (myocyte), Fibrosis (interstitial), Left ventricular dysfunction, Arrhythmias, Markers elevated (troponin), Echocardiographic changes. >14 lymphocytes/mm² confirms diagnosis on endomyocardial biopsy.
| Inflammatory Disease | Primary Pathogen | Diagnostic Criteria | Treatment Duration | Mortality Rate | Recurrence Risk |
|---|---|---|---|---|---|
| Viral Myocarditis | Coxsackievirus B | Troponin + MRI | 3-6 months | 5-10% | 10-15% |
| Giant Cell Myocarditis | Autoimmune | Biopsy required | Lifelong | >80% | High |
| Acute Pericarditis | Viral/Idiopathic | Clinical + ECG | 2-4 weeks | <1% | 20-30% |
| Bacterial Endocarditis | S. aureus | Blood cultures + echo | 4-6 weeks | 15-25% | 5-10% |
| Constrictive Pericarditis | Post-surgical | Catheterization | Surgical | 5-15% | Rare |
💡 Master This: Inflammatory cardiac diseases create distinct histological signatures. Lymphocytic infiltrates indicate viral myocarditis, giant cells suggest autoimmune disease, and neutrophilic infiltrates point to bacterial infection. Endomyocardial biopsy remains gold standard for myocarditis diagnosis with >95% specificity when >14 lymphocytes/mm² are present.
Understanding inflammatory patterns provides the foundation for recognizing how structural heart diseases develop through different pathophysiological mechanisms.
Valvular Diseases (2-7% population prevalence)
Cardiomyopathies (1:500 population prevalence)
Congenital Defects (8 per 1000 live births)
Loading diagram…
📌 Remember: VALVE assessment parameters - Velocity (peak >4 m/s severe AS), Area (effective orifice <1.0 cm² severe), Left ventricular response (hypertrophy >15 mm), Volume overload (regurgitant >60 mL), Ejection fraction (preserved vs reduced). Each parameter has specific thresholds for severity grading.
| Structural Disease | Key Measurement | Severe Threshold | Surgical Indication | 5-Year Survival | Complication Rate |
|---|---|---|---|---|---|
| Aortic Stenosis | Valve Area | <1.0 cm² | Symptoms + severe AS | >95% | <3% |
| Mitral Regurgitation | Regurgitant Volume | >60 mL | EF <60% or ESD >40mm | >90% | <5% |
| Hypertrophic CMP | Septal Thickness | >15 mm | Gradient >50 mmHg | >95% | <2% |
| Dilated CMP | Ejection Fraction | <35% | Heart failure symptoms | Variable | Variable |
| Tetralogy of Fallot | RV/LV Pressure | >0.7 | Cyanosis or symptoms | >90% | 10-15% |
💡 Master This: Structural heart diseases follow predictable remodeling patterns. Pressure overload creates concentric hypertrophy (thick walls, small cavity), while volume overload produces eccentric hypertrophy (thin walls, large cavity). Understanding these geometric adaptations enables precise hemodynamic assessment and optimal timing of surgical interventions.
Recognizing structural patterns establishes the framework for understanding how these anatomical changes create specific clinical presentations requiring targeted diagnostic approaches.
Loading diagram…
Chest Pain Syndromes (8 million ED visits annually)
Heart Failure Presentations (6.5 million Americans affected)
Arrhythmia Patterns (>2.7 million Americans with AFib)
Loading diagram…
📌 Remember: HEART score for chest pain risk stratification - History (0-2 points), ECG (0-2 points), Age (0-2 points), Risk factors (0-2 points), Troponin (0-2 points). Score 0-3 = <2% risk, Score 4-6 = 12-65% risk, Score 7-10 = >65% risk of 30-day MACE.
| Diagnostic Test | Sensitivity | Specificity | Positive Predictive Value | Negative Predictive Value | Time to Result |
|---|---|---|---|---|---|
| Troponin I | >95% | >90% | Variable | >99% | <1 hour |
| ECG | 70-80% | >95% | >90% | 85% | <5 minutes |
| Stress Echo | 85% | 80% | 85% | 80% | 45 minutes |
| Coronary CTA | >95% | 85% | Variable | >99% | 30 minutes |
| BNP | 90% | 75% | Variable | >95% | <30 minutes |
💡 Master This: Diagnostic pattern recognition combines pretest probability assessment with systematic test interpretation. Bayesian reasoning guides test selection where high pretest probability requires high specificity tests, while low pretest probability needs high sensitivity tests. Understanding test characteristics prevents diagnostic errors and optimizes resource utilization.
Mastering diagnostic patterns creates the foundation for developing evidence-based treatment algorithms that optimize patient outcomes through targeted interventions.
Loading diagram…
STEMI Treatment Protocols (door-to-balloon <90 minutes)
NSTEMI/UA Management (risk-stratified approach)
Heart Failure Treatment Algorithms (guideline-directed medical therapy)
📌 Remember: MONA-BASH for acute MI management - Morphine (if needed), Oxygen (if SpO2 <90%), Nitroglycerin (avoid if RV infarct), Aspirin (162-325 mg), Beta-blocker (if no contraindications), ACE inhibitor (start within 24 hours), Statin (high-intensity), Heparin (unfractionated or LMWH).
| Treatment Strategy | Target Population | Primary Endpoint | NNT | Mortality Benefit | Major Bleeding Risk |
|---|---|---|---|---|---|
| Primary PCI | STEMI <12 hours | Reperfusion | 33 | 2-3% absolute | <1% |
| Dual Antiplatelet | ACS patients | Recurrent MI | 67 | 1.5% absolute | 2-4% |
| ACE Inhibitor | Post-MI, HF | CV death | 50 | 2% absolute | Rare |
| Beta-blocker | Post-MI | Sudden death | 84 | 1.2% absolute | Rare |
| High-intensity Statin | ACS | MACE | 74 | 1.4% absolute | <0.1% |
💡 Master This: Treatment algorithms optimize outcomes through systematic risk-benefit analysis. Number needed to treat (NNT) quantifies therapeutic benefit where lower NNT indicates greater efficacy. Dual antiplatelet therapy prevents 1 recurrent MI for every 67 patients treated but causes major bleeding in 2-4%. Understanding these trade-offs enables personalized treatment decisions.
Treatment algorithm mastery provides the foundation for understanding how multiple cardiac conditions interact and require integrated management approaches.
Cardio-Renal Syndrome (>40% of heart failure patients)
Cardio-Oncology Interactions (emerging subspecialty)
Metabolic-Cardiac Connections (diabetes + CVD)
Loading diagram…
📌 Remember: CARDIAC multi-system assessment - Cardio-renal (creatinine trends), Arrhythmia burden (Holter monitoring), Respiratory status (BNP levels), Diabetic control (HbA1c targets), Inflammatory markers (CRP, ESR), Anticoagulation needs (bleeding vs thrombosis risk), Cancer therapy effects (cardiotoxicity screening).
| Integration Domain | Key Biomarker | Monitoring Frequency | Intervention Threshold | Outcome Improvement | Cost-Effectiveness |
|---|---|---|---|---|---|
| Cardio-Renal | Creatinine | Every 48 hours | >0.3 mg/dL rise | 25% mortality reduction | High |
| Cardio-Oncology | Troponin | Every 3 months | >ULN elevation | 80% reversibility | Moderate |
| Diabetes-CVD | HbA1c | Every 3 months | >7% target | 35% HF reduction | Very High |
| Heart-Lung | BNP | Monthly | >400 pg/mL | 30% readmission reduction | High |
| Inflammation | CRP | As indicated | >3 mg/L | Variable | Low |
💡 Master This: Advanced cardiac pathology requires systems thinking where single interventions affect multiple organ systems. SGLT2 inhibitors demonstrate pleiotropic effects beyond glucose control, providing cardiovascular benefits through natriuresis, improved cardiac energetics, and reduced inflammation. Understanding these multi-system interactions enables precision medicine approaches that optimize outcomes across multiple domains simultaneously.
This advanced integration framework establishes the foundation for developing rapid mastery tools that synthesize complex cardiac pathology into actionable clinical knowledge.
Rapid Assessment Framework (<5 minute evaluation)
Diagnostic Hierarchy (evidence-based prioritization)
Treatment Prioritization Matrix (time-sensitive interventions)
Loading diagram…
📌 Remember: CARDIAC mastery checklist - Clinical assessment (history + physical), Acute interventions (time-sensitive), Risk stratification (evidence-based), Diagnostic testing (systematic), Imaging interpretation (structured), Advanced therapies (guideline-directed), Continuous monitoring (outcome-focused). Each element has specific timeframes and measurable endpoints.
| Clinical Scenario | Time to Diagnosis | Key Diagnostic Test | Treatment Window | Success Rate | Mortality Reduction |
|---|---|---|---|---|---|
| STEMI | <10 minutes | ECG | <90 minutes | >95% | 50% relative |
| Cardiogenic Shock | <30 minutes | Echo + Swan-Ganz | <60 minutes | Variable | 30% absolute |
| Acute Heart Failure | <60 minutes | BNP + Echo | <4 hours | >90% | 20% relative |
| Cardiac Tamponade | <15 minutes | Echo | <30 minutes | >95% | Life-saving |
| Aortic Dissection | <30 minutes | CT Angiography | <2 hours | >90% | 40% relative |
💡 Master This: Cardiac pathology mastery requires integration of anatomical knowledge, pathophysiological understanding, clinical correlation, and therapeutic expertise. Expert practitioners develop mental models that enable rapid pattern recognition, accurate risk stratification, and optimal treatment selection. This cognitive framework transforms complex clinical scenarios into manageable decision trees with predictable outcomes and measurable success rates.
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more
1. A 55-year-old woman has had predictable chest pain on climbing four flights of stairs or jogging for three months. Each episode resolves within five minutes of rest. Her mother had a myocardial infarction at 50 years. What is the most likely diagnosis?
Answer: B. Stable angina pectoris
Stable angina pectoris - Stable angina pectoris causes predictable chest pain precipitated by exertion, such as climbing stairs or jogging, because fixed coronary stenosis limits flow when oxygen demand rises. - This represents a demand-supply mismatch: myocardial perfusion is adequate at rest but insufficient during exertion, with symptoms typically relieved by rest or sublingual nitroglycerin. Supraventricular tachycardia - Supraventricular tachycardia typically causes abrupt episodes of rapid palpitations, sometimes with chest discomfort; the supplied predictable exertional pain pattern more strongly supports stable angina. Myocardial infarction - Myocardial infarction is acute myocardial injury with evidence of ischemia and may occur with or without acute coronary occlusion; when chest pain occurs, it is typically prolonged rather than predictably limited to a reproducible exertional threshold. - Infarction is not characterized by this patient’s reproducible exertional pattern with predictable onset; stable symptoms instead suggest fixed stenosis without acute infarction. Prinzmetal angina pectoris - Prinzmetal angina pectoris results from transient coronary vasospasm and characteristically occurs at rest, often during the early morning hours, rather than after predictable exertion. - The patient’s symptoms are consistently triggered by increased physical demand, supporting fixed atherosclerotic obstruction rather than episodic vasospasm.
2. Water hammer pulse is seen in which of the following conditions?
Answer: C. Aortic regurgitation
Aortic regurgitation - In aortic regurgitation, the left ventricle ejects an increased stroke volume because it pumps both normal blood and regurgitated blood. - During diastole, rapid runoff into the left ventricle causes a marked fall in diastolic pressure, producing a wide pulse pressure and collapsing pulse. Mitral regurgitation - Mitral regurgitation generally produces a normal or slightly reduced pulse volume rather than a rapidly collapsing pulse. - The characteristic wide pulse pressure and marked diastolic pressure fall of a water hammer pulse are not typical of isolated mitral regurgitation. Mitral stenosis - Mitral stenosis generally produces a low-volume pulse because left ventricular filling is reduced. It does not characteristically produce the rapid rise and collapse of a water hammer pulse. Aortic stenosis - Aortic stenosis restricts left ventricular outflow, reducing the volume and speed of the arterial pulse. - It classically causes pulsus parvus et tardus, a small-volume, slow-rising pulse, rather than a forceful rapid upstroke with sudden collapse.
3. Which of the following is NOT a typical chest radiographic feature of unrepaired tetralogy of Fallot with reduced pulmonary blood flow?
Answer: B. Pulmonary vascular plethora
Pulmonary vascular plethora - Pulmonary vascular plethora indicates increased pulmonary vascular markings and increased pulmonary blood flow, which is not typical of Tetralogy of Fallot. - Tetralogy of Fallot usually causes pulmonary oligemia because pulmonary outflow obstruction reduces blood flow to the lungs; therefore, plethora is the exception. Boot-shaped cardiac silhouette - A boot-shaped cardiac silhouette is a classic CXR finding in Tetralogy of Fallot, produced by right ventricular hypertrophy and an upturned cardiac apex. - This finding supports Tetralogy of Fallot, which causes pulmonary outflow obstruction and reduced pulmonary blood flow in a cyanotic neonate. Upturned cardiac apex - Upturned cardiac apex is a classic radiographic manifestation of right ventricular hypertrophy in tetralogy of Fallot and contributes to the boot-shaped cardiac silhouette. Right-sided aortic arch - A right-sided aortic arch is a recognized associated anomaly in Tetralogy of Fallot and occurs in approximately 25% of affected patients. - It is not present in every patient, but its association with Tetralogy of Fallot makes it a possible CXR finding rather than the exception.
4. Which condition best explains the ECG changes shown?
Answer: B. Digoxin effect
Digoxin effect - Digoxin characteristically causes downward-sloping ST-segment depression with a sagging or scooped appearance, classically described as a Salvador Dalí mustache. - This repolarization effect results from digoxin-induced shortening of the QT interval and may occur without drug toxicity or other clinical abnormalities. Myocardial injury - Myocardial injury is defined by elevated cardiac troponin and may occur with or without ECG abnormalities; it cannot be diagnosed from ST-segment morphology alone. - The characteristic scooped ST-segment depression favors a digoxin effect rather than myocardial injury, which is not identified by this specific repolarization pattern. Digoxin toxicity - Digoxin toxicity can produce altered ST-T morphology, but it usually causes associated arrhythmias such as ventricular premature beats, bradycardia, or atrioventricular block. - An isolated scooped ST depression indicates digoxin effect but does not establish toxicity without clinical features, arrhythmias, or other supporting evidence. Myocardial ischemia - Myocardial ischemia may cause horizontal or downsloping ST-segment depression, often accompanied by T-wave inversion, but typically lacks the distinctive scooped contour. - The described ST morphology is therefore more consistent with digoxin effect than with ischemic repolarization changes.
5. Which molecular marker characterizes the leukemia primarily treated with all-trans retinoic acid?
Answer: C. PML-RARA
PML-RARA - PML-RARA is the defining fusion gene of acute promyelocytic leukemia, the malignancy for which all-trans retinoic acid is a cornerstone treatment. - ATRA overcomes the PML-RARA-mediated maturation block by inducing differentiation of leukemic promyelocytes. BCR-ABL1 - BCR-ABL1 characterizes chronic myeloid leukemia and some acute lymphoblastic leukemias, rather than the tumor primarily treated with ATRA. - BCR-ABL1-positive leukemias are primarily treated with tyrosine kinase inhibitors, such as imatinib, not all-trans retinoic acid. CEBPA - CEBPA mutations occur in a subset of acute myeloid leukemias and may be associated with favorable prognosis, but they do not define ATRA-responsive disease. - Although ATRA has roles in some AML contexts, its primary indication here is the PML-RARA fusion, not AML with isolated CEBPA mutations. CMYC - CMYC dysregulation is implicated in cancers such as Burkitt lymphoma and some acute myeloid leukemias, but it does not identify the primary ATRA-treated tumor. - There is no direct therapeutic role for ATRA specifically targeting tumors driven by CMYC overexpression.
6. In an infant with congestive heart failure, which is the most reliable clinical sign of systemic venous congestion?
Answer: D. Hepatomegaly
Hepatomegaly - Hepatomegaly is a crucial sign of pediatric CHF because hepatic venous congestion produces enlargement of the compressible liver. - The liver can accommodate substantial increases in blood volume, allowing hepatomegaly to become apparent before other signs of systemic venous congestion. Raised JVP - Raised JVP can indicate systemic venous congestion in older children with CHF, but it is difficult to assess reliably in infants and young children because of their short necks and limited cooperation. - Compared with hepatomegaly, raised JVP is less sensitive and less practical as a diagnostic sign across pediatric age groups, particularly in younger children. Basal crackles - Basal crackles indicate pulmonary edema from pulmonary venous congestion and are therefore more suggestive of left-sided heart failure. - Although crepitations may occur in CHF, hepatomegaly is a more consistent and often earlier finding across different forms of pediatric heart failure. Pedal edema - Pedal edema is less common in pediatric CHF, especially in infants and toddlers, than in adults with systemic venous congestion. - Shorter hydrostatic columns and prolonged supine positioning reduce dependent edema, making pedal swelling less prominent than hepatomegaly.
7. Destination therapy is indicated in which of the following conditions?
Answer: A. End-stage heart failure
End-stage heart failure - Destination therapy is permanent LVAD support for patients with end-stage (Stage D) heart failure who remain symptomatic despite maximal medical therapy. - In severe congestive heart failure, LVAD support can improve systemic perfusion, survival, and quality of life when heart transplantation is unsuitable because of age or comorbidities. Acute anterior myocardial infarction - Acute anterior myocardial infarction is treated acutely with reperfusion, such as percutaneous coronary intervention or thrombolysis, rather than permanent LVAD implantation. - Although an infarction may cause subsequent heart failure, destination therapy is not the acute treatment for myocardial injury or coronary occlusion. Cardiac arrhythmia - Arrhythmias are generally managed with anti-arrhythmic drugs, cardioversion, or an implantable cardioverter-defibrillator, depending on the rhythm and risk. - An arrhythmia alone does not usually cause the refractory pump failure required for destination LVAD therapy; mechanical support is not its standard definitive treatment. Infective endocarditis - Infective endocarditis requires prolonged antimicrobial therapy and, when indicated, valve replacement surgery to eradicate infection and correct structural damage. - Active infection is an important contraindication to LVAD implantation, so endocarditis is not an indication for destination therapy.
8. The thyroid scan shown below exhibits a pattern that is most consistent with which of the following disorders?
Answer: C. Hypersecreting adenoma
Hypersecreting adenoma - A hypersecreting adenoma produces thyroid hormone autonomously and therefore appears as a focal hot nodule with increased tracer uptake. - Excess hormone suppresses TSH secretion, causing reduced uptake in the remaining thyroid tissue and distinguishing this pattern from diffuse thyroid overactivity. Papillary thyroid carcinoma - Papillary carcinoma usually appears as a cold nodule on thyroid scintigraphy because malignant cells generally concentrate iodine less efficiently than normal thyroid tissue. - Although it is the most common thyroid cancer, papillary carcinoma is rarely associated with increased tracer uptake, unlike the described focal hyperfunctioning pattern. Lateral aberrant thyroid - A lateral aberrant thyroid generally refers to thyroid tissue or metastatic thyroid carcinoma in a cervical lymph node, producing uptake outside the thyroid gland. - It would not explain a focal hot nodule within the thyroid with suppression of the surrounding gland, which indicates autonomous intrathyroidal function. Graves' hyperthyroidism - Graves' disease causes generalized stimulation of thyroid follicular cells by autoantibodies, producing diffuse increased uptake throughout the gland. - The expected scan is a uniformly active thyroid, not a single hot focus with suppressed uptake in the remaining tissue.
9. Assertion: Myocarditis is seen as a complication in faucial diphtheria. Reason: It is due to the exotoxin produced by Corynebacterium diphtheriae. Which option correctly describes the truth of these statements and their relationship?
Answer: D. Assertion is true; reason is true and explains the assertion
Assertion is true; reason is true and explains the assertion - Myocarditis is a recognized complication of faucial diphtheria. The exotoxin produced by Corynebacterium diphtheriae causes myocardial injury, directly explaining the assertion. Assertion is true; reason is true but does not explain the assertion - Both statements are true, but the reason directly explains why myocarditis occurs; therefore, this option is incorrect. Assertion is false; reason is true but does not explain the assertion - The assertion is not false: myocarditis is a well-established complication of faucial diphtheria. The reason is true and directly explains the assertion. Assertion is true; reason is false and does not explain the assertion - The reason is not false: diphtheria exotoxin causes myocardial injury and directly explains the occurrence of myocarditis.
10. Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?
Answer: B. Atrial fibrillation
Atrial fibrillation is the indication described: digitalis increases vagal influence and AV nodal refractoriness, reducing the ventricular response. Ventricular tachycardia originates below the AV node and is not treated by digitalis-mediated AV nodal slowing. Multifocal atrial tachycardia is managed by correcting precipitating factors and using appropriate rate-control agents; digitalis is not effective treatment. Sinus tachycardia requires treatment of its cause, and digitalis is not the indicated rate-control treatment for mitral stenosis in sinus rhythm.
1. _____, secondary to rheumatic fever, is characterized by small inflammatory vegetations along valvular lines of closure, which cause _____
Endocarditis · regurgitation
2. In rheumatic heart disease, subendocardial lesions may induce irregular thickenings called
McCallum plaques
3. _____ cardiomyopathy may be caused by _____, which is a thick fibroelastic tissue in the endocardium; most commonly affects _____
Restrictive · endocardial fibroelastosis · young children
4. The hyaline, eosinophilic deposits seen on the biopsy point to a diagnosis of cardiac amyloidosis, which most commonly leads to cardiomyopathy.
restrictive
5. On biopsy of a heart with myocarditis, a _____ infiltrate with _____ necrosis is highly indicative of viral myocarditis
lymphocytic · focal
6. One complication of atherosclerosis is _____, which may result from plaque rupture with _____ of the coronary artery
myocardial infarction · thrombosis
7. The hyaline, eosinophilic deposits seen on the biopsy point to a diagnosis of cardiac amyloidosis, which most commonly leads to _____ cardiomyopathy.
restrictive
8. _____ cardiomyopathy is characterized by myofibrillar hypertrophy with _____ and fibrosis on biopsy
Hypertrophic · disarray
9. Aschoff's bodies in rheumatic heart disease shows _____ necrosis.
fibrinoid
10. _____ disease is a glycogen storage disease associated with _____ cardiomyopathy
Pompe · hypertrophic
Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.
Scan to download app
Enter your email to get your 75% OFF code and unlock the full Indian Medical PG question bank on the app.